IPX203

DRUG2 trials

Sponsors

Impax Laboratories, LLC

Conditions

Advanced Parkinson's DiseaseParkinson Disease

Phase 2

A Study to Assess the PK and Pharmacodynamics of IPX203 in Subjects With Advanced Parkinson's Disease

CompletedNCT03007888

Impax Laboratories, LLCAdvanced Parkinson's Disease

Start: 2016-11-14End: 2017-08-01Updated: 2022-06-06

Phase 3

Open Label Extension (OLE) Study of the Safety and Clinical Utility of IPX203 in Parkinson's Disease (PD) Participants With Motor Fluctuations

CompletedNCT03877510

Impax Laboratories, LLCParkinson Disease

Start: 2019-04-03End: 2022-03-21Updated: 2023-07-13